Skip to main content
Log in

B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Coronary artery disease is the primary cause of death in the United States, with obesity as a leading preventable risk factor. Previous studies have established the beneficial effect of Roux-en-Y gastric bypass on both weight and cardiac risk factors. Further assessment of cardiac function may be accomplished using B-type natriuretic peptide (BNP), which has demonstrated clinical utility in diagnosing congestive heart failure. This study aimed to assess changes in BNP after intentional weight loss through gastric bypass surgery.

Methods

Plasma volume, weight, and BNP were measured preoperatively and at 3, 6, and 12 months postoperatively for 101 consecutive patients undergoing laparoscopic gastric bypass surgery by a single surgeon in an academic medical setting. Outcomes were compared by matched t-test. Multivariable linear regression and Pearson’s correlation were used to examine predictors of pro-B-type natriuretic peptide (NT-proBNP) concentration.

Results

The concentration of BNP increased significantly from a mean preoperative level of 50.5 ng/l to postoperative levels of 73.9 ng/l at 3 months (P = 0.013), 74.3 ng/l at 6 months (P < 0.001), and 156.3 ng/l at 12 months (P < 0.001). In addition, excess weight loss was the only statistically significant predictor of increased BNP concentration (odds ratio, 1.483; P < 0.05).

Conclusion

Gastric bypass leads to significant excess weight loss and surprisingly increased BNP concentrations. Correlation of BNP increase with weight loss suggests an additional novel mechanism for surgically induced weight loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease. J Am Coll Cardiol 53:1925–1932

    Article  PubMed  Google Scholar 

  2. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50:2357–2368

    Article  PubMed  CAS  Google Scholar 

  3. Steiner J, Guglin M (2008) BNP or NTproBNP? A clinician’s perspective. Int J Cardiol 129:5–14

    Article  PubMed  Google Scholar 

  4. Ryding AD, Kumar S, Worthington AM, Burgess D (2009) Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 111:311–319

    Article  PubMed  CAS  Google Scholar 

  5. Tacoy G, Acikgoz K, Kocaman SA, Ozdemir M, Cengel A (2010) Is there a relationship between obesity, heart rate variability, and inflammatory parameters in heart failure? J Cardiovasc Med Hagerstown 11:118–124

    Article  PubMed  Google Scholar 

  6. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS (2004) Impact of obesity on plasma naturietic peptide levels. Circulation 109:594–600

    Article  PubMed  CAS  Google Scholar 

  7. St. Peter JV, Hartley GG, Murakami MM, Apple FS (2006) B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem 52:680–685

    Article  PubMed  CAS  Google Scholar 

  8. Hanusch-Enserer U, Hermann K, Cauza E (2003) Effect of gastric banding on aminoterminal pro-brain natriuertic peptide in the morbidly obese. Obesity Res 6:695–698

    Article  Google Scholar 

  9. Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS (2006) B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 152:1071–1076

    Article  PubMed  CAS  Google Scholar 

  10. Bayes-Genis A, DeFilippi C, Januzzi JL Jr (2008) Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol 101:89–94

    Article  PubMed  Google Scholar 

  11. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, McMurray JJ (2007) Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 28:829–835

    Article  PubMed  CAS  Google Scholar 

  12. Crandall DL, Ferraro GD, Cervoni P (1989) Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc Soc Exp Biol Med 191:352–356

    PubMed  CAS  Google Scholar 

  13. Williams DB, Hagedorn JC, Lawson EH, Galanko JA, Safadi BY, Curet MC, Morton JM (2007) Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis 3:8–13

    Article  PubMed  Google Scholar 

  14. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A (1996) Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 19:581–585

    PubMed  CAS  Google Scholar 

  15. Jhaveri RR, Pond KK, Hauser TH, Kissinger KV, Goepfert L, Schneider B, Jones DB, Manning WJ (2009) Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery. Surg Obes Relat Dis 5:648–652

    Article  PubMed  Google Scholar 

  16. Garcia S, Akbar MS, Ali SS, Kamdar F, Tsai MY, Duprez DA (2010) N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy. Int J Cardiol 143(3):349–352

    Article  PubMed  Google Scholar 

  17. Hsuan CF, Huang CK, Lin JW, Lin LC, Lee TL, Tai CM, Yin WH, Tseng WK, Hsu KL, Wu CC (2010) The effect of surgical weight reduction on left ventricular structure and function in severe obesity. Obesity (Silver Spring) 18(6):1188–1193

    Article  Google Scholar 

  18. Karason K, Wallentin I, Larsson B, Sjostrom L (1997) Effects of obestiy and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 315:912–916

    PubMed  CAS  Google Scholar 

  19. Mianmi J, Nishikimi T, Matsuoka H, Wang TJ, Larson MG, Levy D, Benjamin E, Leip EP, Wilson PWF, Vasan RS (2004) Plasma brain natriuretic peptide and N-terminal proatrial natriuretic peptide levels in obese patients: a cause or result of hypertension? Circulation 110:e76

    Article  Google Scholar 

  20. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Ozazaki H, Asai M, Nagamachi Y, Maeda N, Shintani Y, Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H, Kitakaze M (2009) Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 53:2070–2077

    Article  PubMed  CAS  Google Scholar 

  21. Sandek A, Doehner W, Anker SD, von Haehling S (2009) Nutrition in heart failure: an update. Curr Opin Clin Nutr Metab Care 12:384–391

    Article  PubMed  Google Scholar 

  22. Chang LC, Huang KC, Wu YW, Kao HL, Chen CL, Lai LP, Hwang JJ, Yang WS (2009) The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc 108:353–366

    Article  PubMed  Google Scholar 

  23. Celik T, Yaman T (2010) Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia? Int J Cardiol 144(2):319–320

    Article  PubMed  Google Scholar 

  24. Du Bois EF (1916) A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med XVII(6_2):863–871

    Google Scholar 

Download references

Disclosures

John Morton has an educational Grant from Ethicon Endo-Surgery. Eric M. Changchien, Shushmita Ahmed, Francesca Betti, Jennifer Higa, Kate Kiely, and Tina Hernandez-Boussard have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Morton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Changchien, E.M., Ahmed, S., Betti, F. et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc 25, 2338–2343 (2011). https://doi.org/10.1007/s00464-010-1565-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-010-1565-1

Keywords

Navigation